REPORT FROM THE 15TH INTERNATIONAL MEETING OF PARKINSON’S DISEASE AND MOVEMENT DISORDERS, TORONTO, JUNE 5-9, 2011 – The dopamine agonist apomorphine has demonstrated efficacy as a rescue therapy for end-of-dose wearing-off motor fluctuations in patients with advanced Parkinson’s disease who are receiving optimal antiparkinsonian medications (Chen & Obering. Clin Ther 2005; 27: 1710-1724).